Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Secondary Sources
1.3.3 Primary Research
1.3.4 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1
1.11.2 Objective 2
1.12 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Popular Screening Market Variables, Trends & Scope
3.1 Population Screening Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.1.1 Cellular Health Screening Market Outlook
3.1.1.2 In Vitro Diagnostics Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Market Driver Analysis
3.3.1 Increasing Prevalence Of Diseases
3.3.2 Growing Investments In Population Screening
3.3.3 Growing Geriatric Population
3.4 Market Restraint Analysis
3.4.1 High Cost Associated With Screening
3.4.2 Psychological Factors, Knowledge, Attitudes, And Beliefs
3.5 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.6 Porter’s Five Forces Analysis
3.7 Regulatory Framework
Chapter 4 Population Screening Market – Segment Analysis, by Geography, 2018 – 2030 (USD Million)
4.1 Definition and Scope
4.2 Population Screening Market: Geography Movement Analysis
4.2.1 Nation
4.2.1.1 Nation Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.2.2 State
4.2.2.1 State market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 5 Population Screening Market – Segment Analysis, by Product, 2018 – 2030 (USD Million)
5.1 Population Screening Market: Product Movement Analysis
5.1.1 Hardware Equipment (Instrument, Kits, Chips)
5.1.1.1 Hardware Equipment (Instrument, Kits, Chips) Market Estimates And Forecast, 2018 – 2030 (Usd Million)
5.1.2 Testing/Lab (Services)
5.1.2.1 Testing/Lab (Services) Market Estimates And Forecast, 2018 – 2030 (Usd Million)
5.1.3 Analytics/Interpretation (Personalization And Interpretation)
5.1.3.1 Analytics/Interpretation (Personalisation and interpretation) market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 6 Population Screening Market – Segment Analysis, by Business, 2018 – 2030 (USD Million)
6.1 Definition and Scope
6.2 Population Screening Market: Business Movement Analysis
6.2.1 Hospitals
6.2.1.1 Hospitals Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.2.2 Research Institutes
6.2.2.1 Research Institutes Market Estimates And Forecast, 2018 – 2030 (Usd Million)
6.2.3 Diagnostic Labs
6.2.3.1 Diagnostic labs market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 7 Population Screening Market – Segment Analysis, by Gender, 2018 – 2030 (USD Million)
7.1 Definition and Scope
7.2 Population Screening Market: Gender Movement Analysis
7.2.1 Male
7.2.1.1 Male Market Estimates And Forecast, 2018 – 2030 (Usd Million)
7.2.2 Female
7.2.2.1 Female market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 8 Population Screening Market – Segment Analysis, by Type, 2018 – 2030 (USD Million)
8.1 Definition and Scope
8.2 Population Screening Market: Type Movement Analysis
8.2.1 Mass
8.2.1.1 Mass Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.2.2 Premium
8.2.2.1 Premium market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 9 Population Screening Market – Segment Analysis, by Age, 2018 – 2030 (USD Million)
9.1 Definition and Scope
9.2 Population Screening Market: Age Movement Analysis
9.2.1 Age <15
9.2.1.1 Age 9.2.2 15-65
9.2.2.1 15-65 Market Estimates And Forecast, 2018 – 2030 (USD Million)
9.2.3 Ages 65+
9.2.3.1 Ages 65+ market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 10 Regional Business Analysis
10.1 Definition & Scope
10.2 Regional Market Share Analysis, 2021 & 2030
10.3 Regional Market Dashboard
10.4 Regional Market Snapshot
10.5 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
10.5.1 North America
10.5.2 Europe
10.5.3 Asia Pacific
10.5.4 Latin America
10.5.5 MEA
10.6 Market Size, & Forecasts, Trend Analysis, 2021 to 2030
10.7 North America
10.7.1 North America Market Estimates And Forecast, 2018 – 2030 (USD MILLION)
10.7.2 U.S.
10.7.2.1 U.S. Population Screening Market, 2018 – 2030 (USD Million)
10.7.2.2 Key country Dynamics
10.7.2.3 Regulatory Framework
10.7.2.4 Competitive Scenario
10.7.2.5 Recent Developments
10.7.2.6 Investments Scenario
10.7.3 Canada
10.7.3.1 Canada Population Screening Market, 2018 – 2030 (USD Million)
10.7.3.2 Key country Dynamics
10.7.3.3 Regulatory Framework
10.7.3.4 Competitive Scenario
10.7.3.5 Recent Developments
10.7.3.6 Investments Scenario
10.8 Europe
10.8.1 Europe Population Screening Market, 2018 – 2030 (USD Million)
10.8.2 UK
10.8.2.1 UK Population Screening Market, 2018 – 2030 (USD Million)
10.8.2.2 Key country Dynamics
10.8.2.3 Regulatory Framework
10.8.2.4 Competitive Scenario
10.8.2.5 Recent Developments
10.8.2.6 Investments Scenario
10.8.3 Germany
10.8.3.1 Germany Population Screening Market, 2018 – 2030 (USD Million)
10.8.3.2 Key country Dynamics
10.8.3.3 Regulatory Framework
10.8.3.4 Competitive Scenario
10.8.3.5 Recent Developments
10.8.3.6 Investments Scenario
10.8.4 Spain
10.8.4.1 Spain Population Screening Market, 2018 – 2030 (USD Million)
10.8.4.2 Key country Dynamics
10.8.4.3 Regulatory Framework
10.8.4.4 Competitive Scenario
10.8.4.5 Recent Developments
10.8.4.6 Investments Scenario
10.8.5 France
10.8.5.1 France Population Screening Market, 2018 – 2030 (USD Million)
10.8.5.2 Key country Dynamics
10.8.5.3 Regulatory Framework
10.8.5.4 Competitive Scenario
10.8.5.5 Recent Developments
10.8.5.6 Investments Scenario
10.8.6 Italy
10.8.6.1 Italy Population Screening Market, 2018 – 2030 (USD Million)
10.8.6.2 Key country Dynamics
10.8.6.3 Regulatory Framework
10.8.6.4 Competitive Scenario
10.8.6.5 Recent Developments
10.8.6.6 Investments Scenario
10.8.7 Denmark
10.8.7.1 Denmark Population Screening Market, 2018 – 2030 (USD Million)
10.8.7.2 Key country Dynamics
10.8.7.3 Regulatory Framework
10.8.7.4 Competitive Scenario
10.8.7.5 Recent Developments
10.8.7.6 Investments Scenario
10.8.8 Sweden
10.8.8.1 Sweden Population Screening Market, 2018 – 2030 (USD Million)
10.8.8.2 Key country Dynamics
10.8.8.3 Regulatory Framework
10.8.8.4 Competitive Scenario
10.8.8.5 Recent Developments
10.8.8.6 Investments Scenario
10.8.9 Norway
10.8.9.1 Norway Population Screening Market, 2018 – 2030 (USD Million)
10.8.9.2 Key country Dynamics
10.8.9.3 Regulatory Framework
10.8.9.4 Competitive Scenario
10.8.9.5 Recent Developments
10.8.9.6 Investments Scenario
10.9 Asia Pacific
10.9.1 Asia-Pacific Population Screening Market, 2018 – 2030 (USD Million)
10.9.2 Japan
10.9.2.1 Japan Population Screening Market, 2018 – 2030 (Usd Million)
10.9.2.2 Key Country Dynamics
10.9.2.3 Regulatory Framework
10.9.2.4 Competitive Scenario
10.9.2.5 Recent Developments
10.9.2.6 Investments Scenario
10.9.3 China
10.9.3.1 China Population Screening Market, 2018 – 2030 (Usd Million)
10.9.3.2 Key Country Dynamics
10.9.3.3 Regulatory Framework
10.9.3.4 Competitive Scenario
10.9.3.5 Recent Developments
10.9.3.6 Investments Scenario
10.9.4 India
10.9.4.1 India Population Screening Market, 2018 – 2030 (Usd Million)
10.9.4.2 Key Country Dynamics
10.9.4.3 Regulatory Framework
10.9.4.4 Competitive Scenario
10.9.4.5 Recent Developments
10.9.4.6 Investments Scenario
10.9.5 South Korea
10.9.5.1 South Korea Population Screening Market, 2018 – 2030 (Usd Million)
10.9.5.2 Key Country Dynamics
10.9.5.3 Regulatory Framework
10.9.5.4 Competitive Scenario
10.9.5.5 Recent Developments
10.9.5.6 Investments Scenario
10.9.6 Thailand
10.9.6.1 Thailand Population Screening Market, 2018 – 2030 (Usd Million)
10.9.6.2 Key Country Dynamics
10.9.6.3 Regulatory Framework
10.9.6.4 Competitive Scenario
10.9.6.5 Recent Developments
10.9.6.6 Investments Scenario
10.9.7 Australia
10.9.7.1 Australia Population Screening Market, 2018 – 2030 (USD Million)
10.9.7.2 Key country Dynamics
10.9.7.3 Regulatory Framework
10.9.7.4 Competitive Scenario
10.9.7.5 Recent Developments
10.9.7.6 Investments Scenario
10.10 Latin America
10.10.1 Latin America Population Screening Market, 2018 – 2030 (USD Million)
10.10.2 Brazil
10.10.2.1 Brazil Population Screening Market, 2018 – 2030 (Usd Million)
10.10.2.2 Key Country Dynamics
10.10.2.3 Regulatory Framework
10.10.2.4 Competitive Scenario
10.10.2.5 Recent Developments
10.10.2.6 Investments Scenario
10.10.3 Mexico
10.10.3.1 Mexico Population Screening Market, 2018 – 2030 (Usd Million)
10.10.3.2 Key Country Dynamics
10.10.3.3 Regulatory Framework
10.10.3.4 Competitive Scenario
10.10.3.5 Recent Developments
10.10.3.6 Investments Scenario
10.10.4 Argentina
10.10.4.1 Argentina Population Screening Market, 2018 – 2030 (Usd Million)
10.10.4.2 Key Country Dynamics
10.10.4.3 Regulatory Framework
10.10.4.4 Competitive Scenario
10.10.4.5 Recent Developments
10.10.4.6 Investments Scenario
10.11 MEA
10.11.1 Mea Population Screening Market, 2018 – 2030 (Usd Million)
10.11.2 South Africa
10.11.2.1 South Africa Population Screening Market, 2018 – 2030 (Usd Million)
10.11.2.2 Key Country Dynamics
10.11.2.3 Regulatory Framework
10.11.2.4 Competitive Scenario
10.11.2.5 Recent Developments
10.11.2.6 Investments Scenario
10.11.3 Saudi Arabia
10.11.3.1 Saudi Arabia Population Screening Market, 2018 – 2030 (Usd Million)
10.11.3.2 Key Country Dynamics
10.11.3.3 Regulatory Framework
10.11.3.4 Competitive Scenario
10.11.3.5 Recent Developments
10.11.3.6 Investments Scenario
10.11.4 UAE
10.11.4.1 Uae Population Screening Market, 2018 – 2030 (Usd Million)
10.11.4.2 Key Country Dynamics
10.11.4.3 Regulatory Framework
10.11.4.4 Competitive Scenario
10.11.4.5 Recent Developments
10.11.4.6 Investments Scenario
10.11.5 Kuwait
10.11.5.1 Kuwait Population Screening Market, 2018 – 2030 (USD Million)
10.11.5.2 Key country Dynamics
10.11.5.3 Regulatory Framework
10.11.5.4 Competitive Scenario
10.11.5.5 Recent Developments
10.11.5.6 Investments Scenario
Chapter 11 Competitive Analysis
11.1 Company/Competition Categorization (Key Innovators, Market leaders, Emerging Players)
11.2 Strategy Framework
11.3 Market Participation Categorization
11.4 Recent Developments & Impact Analysis, by Key Market Participants
11.5 Company Position Analysis
11.6 List of Distributors
11.6.1 Key Customers
11.6.2 Public Companies
11.6.3 Private Companies
11.7 Case Studies
11.7.1 Cost Analysis Of Cvd Patients With Screening Vs No Screening
11.7.2 Case Study: Population Health Screening
11.7.3 Case Study: Screening Of Raw Cases Samples Using The Agilent Quickprobe Gc/Ms System
11.7.4 Case Study: Evaluate The Performance Of Roche Cobas 4800 Hpv Test For Evaluating Hpv Tests For Screening
11.7.5 Case Study: Measurement Of Glucose And Hemoglobin In Diabetes
Chapter 12 COMPANY PROFILES
12.1 Company Profiles
12.1.1 AGILENT TECHNOLOGIES, INC.
12.1.1.1 Company Overview
12.1.1.2 Financial Performance
12.1.1.3 Product Benchmarking
12.1.1.4 Strategic Initiatives
12.1.2 THERMO FISHER SCIENTIFIC, INC.
12.1.2.1 Company Overview
12.1.2.2 Financial performance
12.1.2.3 Product Benchmarking
12.1.2.4 Strategic Initiatives
12.1.3 QIAGEN
12.1.3.1 Company Overview
12.1.3.2 Financial performance
12.1.3.3 Product Benchmarking
12.1.3.4 Strategic Initiatives
12.1.4 F. HOFFMANN-LA ROCHE LTD
12.1.4.1 Company Overview
12.1.4.2 Financial performance
12.1.4.3 Product Benchmarking
12.1.4.4 Strategic Initiatives
12.1.5 QUEST DIAGNOSTICS
12.1.5.1 Company Overview
12.1.5.2 Financial performance
12.1.5.3 Product Benchmarking
12.1.5.4 Strategic Initiatives
12.1.6 ILLUMINA, INC
12.1.6.1 Company Overview
12.1.6.2 Financial performance
12.1.6.3 Product Benchmarking
12.1.6.4 Strategic Initiatives
12.1.7 ARUP LABORATORIES
12.1.7.1 Company Overview
12.1.7.2 Product Benchmarking
12.1.7.3 Strategic Initiatives
12.1.8 NOVOGENE CO., LTD.
12.1.8.1 Company Overview
12.1.8.2 Product Benchmarking
12.1.8.3 Strategic Initiatives
12.1.9 LGC LIMITED
12.1.9.1 Company Overview
12.1.9.2 Product Benchmarking
12.1.9.3 Strategic Initiatives
12.1.10 GENE BY GENE, LTD.
12.1.10.1 Company Overview
12.1.10.2 Product Benchmarking
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
